Resources Contact Us Home
Hybrid immunoglobulin-thrombolytic enzyme molecules which specifically bind a thrombus, and methods of their production and use

Image Number 12 for United States Patent #5609869.

Hybrid immunoglobulin-enzyme molecules are provided which are composed of antibodies, or derivatives or fragments thereof, which specifically bind an arterial or venous thrombus that are operably linked to the enzymatically active portions of thrombolytic enzymes such as plasminogen activators. In a preferred embodiment the hybrid molecules specifically bind to fibrin and have fibrinolytic activity. The hybrid molecules of the present invention may be produced by any means, including chemical conjugation, or by means of recombinant DNA, genetic engineering and/or hybridoma technology. Methods for making and using the molecules in diagnosis and therapy are also disclosed.

  Recently Added Patents
Video surveillance system employing video primitives
Systems and methods for determining muscle force through dynamic gain optimization of a muscle PID controller for designing a replacement prosthetic joint
Digital video disc player
Account and customer creation in an on-line banking model
Bundled flexible cable with water resistant structure
Technique for manufacturing bit patterned media
High performance data transport system and method
  Randomly Featured Patents
Perpetual calendar clock
Rotary piston pump of axial type
Control information transmission apparatus for use in time division multiplex communication systems
Control device for internal combustion engine
Internal chamber for food container
Method and structure to improve body effect and junction capacitance
Processes and systems for making inorganic fibers
Tire tread
Metered dose dispensing aerosol valve
Method and apparatus for producing titanium